RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 for the growth of human leukemic cells in monolayer or suspension. RPMI-1640 medium is a multipurpose medium with many applications for a wide range of mammalian cell lines, such as the Jurkat cell line, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes.
RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 for the growth of human leukemic cells in monolayer or suspension.
RPMI-1640 medium is a multipurpose medium with many applications for a wide range of mammalian cell lines, such as the Jurkat cell line, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes.
Its formulation contains no sodium bicarbonate and phenol red. This reference contains L-Glutamine and Hepes (25mM).
Shipping conditions: Room temperature or refrigerated transport
State: Powder
Shelf life: 24 months
Storage: 2°C/+8°C
Sterility: Non-sterile
Price | 1.326,00 RON (preturile sunt fara TVA) |
---|---|
Description |
RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 for the growth of human leukemic cells in monolayer or suspension. RPMI-1640 medium is a multipurpose medium with many applications for a wide range of mammalian cell lines, such as the Jurkat cell line, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes. Its formulation contains no sodium bicarbonate and phenol red. This reference contains L-Glutamine and Hepes (25mM). Shipping conditions: Room temperature or refrigerated transport |